eLife Articulates Its Media Policy, and Risks Some of Its Editorial Power
eLife clarifies its media policies, adopting the mask of an enlightened approach that actually makes it harder for everyone to generate much attention.
eLife clarifies its media policies, adopting the mask of an enlightened approach that actually makes it harder for everyone to generate much attention.
A fundamental confusion between articles and data leads to a call for more CC licenses and less copyright. But why are data being closed down while articles are being opened up? Is there a fundamental misunderstanding of copyright, licensing, and rights?
More information emerges about PubMed Central, its processes, its relationship with eLife, and its role as a technology provider. Overall, it looks like certain OA friends get special treatment, and the processes you think occur are often short-circuited and may not even be tracked.
Value-based pricing of unique journal products may make sense from a revenue perspective, but not from a sustainability perspective. What are the options?
Last week, PubMed Central became the primary and sole publisher of eLife content, putting its competition with publishers, its manipulation of PubMed indexing criteria, its competition with publishing technology companies, and its clear OA bias into stark relief.
Funder-sponsored journals raise important conflict of interest questions, and may be fundamentally untenable in an industry that requires independent third-party evaluation of research reports.
AAP and Google have reached a confidential settlement over Google Books. But the larger Authors Guild case remains.
A flash mob of concern causes PLoS to reconsider a new policy on retractions.
While the effect of piracy on some book sales is still debatable, college textbooks lose sales when online file-sharing becomes prevalent. A recent examination of the situation in a market outside the U.S. provides a laboratory example.
Articles deposited into PubMed Central responsible for drawing readers from journal site, a study finds.
Most publishers offering delayed free access to journal articles set their embargo period more than a decade ago. Is it time to revisit the access embargo?
The author recounts an experience in which one of his blog posts. He was saved when an Internet community rode to his rescue.
An analyst frets that Elsevier might suffer from the trends in OA publishing and its mandates. But there’s no logical or practical reason to believe this.
When someone is treated unfairly — through pay discrimination — it’s so obvious, even a primate knows it.
While block grants may be a preferred way to disperse money to fund public access mandates, their actual use may cause problems for researchers and universities.